Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Glycorex Transplantation

Glycorex Transplantation
PUBLIC STATUS
21-30 EMPLOYEES
GTAB B STOCK SYMBOL
$1.40 SHARE PRICE (As of Friday Closing)
Description

Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Medical Supplies
Other Industries
Surgical Devices
Stock Exchange
NGM
Primary Office
  • Solvegatan 41
  • 223 70 Lund
  • Sweden

+46 046-286 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Glycorex Transplantation’s full profile, request a free trial.

Glycorex Transplantation Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.25 - $1.66 $101M $1.45 $0.01 207K 69.9M

Glycorex Transplantation Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 49,366 14,753 17,676 21,312
Revenue 4,087 3,838 3,459 3,906
EBITDA 1,257 458 104 430
Net Income 792 329 (1,855) 138
Total Assets 8,455 7,444 6,687 7,804
Total Debt 1,269 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer